Tactile Systems Technology Inc
NASDAQ:TCMD

Watchlist Manager
Tactile Systems Technology Inc Logo
Tactile Systems Technology Inc
NASDAQ:TCMD
Watchlist
Price: 18.33 USD -3.12% Market Closed
Market Cap: 439.9m USD
Have any thoughts about
Tactile Systems Technology Inc?
Write Note

Tactile Systems Technology Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tactile Systems Technology Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Tactile Systems Technology Inc
NASDAQ:TCMD
Income from Continuing Operations
$32.6m
CAGR 3-Years
34%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Income from Continuing Operations
$1.7B
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Income from Continuing Operations
$1.8B
CAGR 3-Years
16%
CAGR 5-Years
12%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Income from Continuing Operations
$3.6B
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Income from Continuing Operations
$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
12%
CAGR 10-Years
14%
Intuitive Surgical Inc
NASDAQ:ISRG
Income from Continuing Operations
$2.3B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
18%
No Stocks Found

Tactile Systems Technology Inc
Glance View

Market Cap
439.3m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
21.22 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Tactile Systems Technology Inc's Income from Continuing Operations?
Income from Continuing Operations
32.6m USD

Based on the financial report for Jun 30, 2024, Tactile Systems Technology Inc's Income from Continuing Operations amounts to 32.6m USD.

What is Tactile Systems Technology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
31%

Over the last year, the Income from Continuing Operations growth was 9 212%. The average annual Income from Continuing Operations growth rates for Tactile Systems Technology Inc have been 34% over the past three years , 31% over the past five years .

Back to Top